COVID Likely to Peak in Colder Months as Virus Becomes Endemic in the US
As COVID-19 becomes endemic in the U.S., it will likely settle into a seasonable rhythm like influenza, becoming most active during the colder months in northern climes and subsiding in summer, according to a new study by researchers at the Yale School of Public Health and the University of North Carolina at Charlotte.
Alumni Day highlights data-driven leadership
More than 100 Yale School of Public Health alumni turned out for the first in-person Alumni Day in five years on Oct. 6, attending an event-filled day at the New Haven Lawn Club that included lively discussions about the importance of data-driven leadership in public health, a poster contest, and the distribution of the annual alumni awards.
NIDA Invests Nearly $7M to Address the Opioid Crisis Among Women Who Experience Intimate Partner Violence
The National Institutes of Health and National Institute on Drug Abuse has awarded nearly $7 million to MPIs Tami Sullivan, PhD (Psychiatry and Public Health); E. Jennifer Edelman, MD, MHS (Internal Medicine and Public Health); and Dawn Johnson, PhD (University of Akron Department of Psychology) to study medication for opioid use disorder treatment retention among women who experience intimate partner violence.
Yale Cancer Center gives guidance for cancer patients who want COVID boosters
While most people who contracted the COVID-19 virus are back to enjoying their normal activities surrounded by others, that’s not the case for those who have undergone cancer or leukemia treatments and have weakened immune systems. Yale Cancer Center researcher Jeffrey Townsend decided to make that dilemma his recent focus. He extrapolated data from many studies already done on COVID-19. Townsend said the Centers for Disease Control Preventions’ guidelines for immunocompromised patients is to get boosters “as needed.” Wanting to know more, Townsend set out with another researcher to give patients some guidance based on science.Source: WTNH News 8
Engaging People with Low-Grade Glioma in Cancer Research
Some people with low-grade glioma, a type of brain tumor, can live for years, even decades, without the disease worsening. But eventually these cancers start to grow, and little is known about why—or how—this happens. An NCI-supported study called OPTIMUMExit Disclaimer (Optimizing Engagement in Discovery of Molecular Evolution of Low-Grade Glioma) could provide some answers.Source: National Cancer Institute
Research reveals boosting strategies that mitigate risks of COVID-19 in cancer patients
New research led by scientists at Yale University and the University of North Carolina at Charlotte finds that the rate at which additional COVID-19 boosters are needed for cancer patients depends on the treatment they are receiving.
Prominent Statistician Opens Dean’s Speaker Series
Big data has transformed the landscape of modern public health research. But there are limits to its applications and researchers need to pay more attention to potential biases. That was the key message delivered by prominent statistician Professor Bhramar Mukherjee, who presented the inaugural lecture for the Yale School of Public Health's new “Leaders in Public Health" speaker series.
When should I get another COVID booster?
Even as Covid-19 recedes from its position as America’s third-leading cause of death in 2022, it remains on track to be a top-ten cause of death this year with the emergence of new variants, such as XBB.1.5 (representing 84 percent of U.S. cases as of April 1). Given the latest federal guidelines on boosters, the public understandably seeks clarity about what this all means for them. Here’s what you need to know about getting your next vaccine.Source: Smithsonian Magazine